Long-term Efficacy of Carglumic Acid in Organic Acidemia.

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 28, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

March 11, 2025

Conditions
Propionic Acidemia (PA) , Methylmalonic Acidemia (MMA)
Interventions
DRUG

Carglumic Acid (Carbaglu®)

"A. Study period: 36 months; treatment period: 12 months.~B. Patients will receive Carglumic Acid (Carbaglu®) 50 mg/kg/day in addition to standard therapy (protein restricted diet, L-carnitine, metronidazole and vitamin B12).~C. Patients need to regularly come back for follow up examination on Day 0, month 3, month 6, and month 12.~D. Patients should report any adverse event that occur during treatment period.~E. Patients' number of emergency visits due to hyperammonemia, ammonia level, acylcarnitine, urinary organic acid analysis, plasma amino acid analysis and methylmalonic acid will be recorded during treatment period."

Trial Locations (1)

10041

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT04284917 - Long-term Efficacy of Carglumic Acid in Organic Acidemia. | Biotech Hunter | Biotech Hunter